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Possible Relationship between Metabolic Syndrome Traits and 
Nephrolithiasis: Incidence for 15 Years According to Gender
Hui Seok Jung, In Ho Chang, Kyung Do Kim, Young Tae Moon, Tae-Hyoung Kim, 
Soon Chul Myung, Young Sun Kim, Jong Yeon Lee
Department of Urology, Chung-Ang University College of Medicine, Seoul, Korea
Purpose: To analyze the independent effect of metabolic syndrome (MS) on neph-
rolithiasis (NL) despite differences in gender compared with the known lithogenic 
factors.
Materials and Methods: From 1995 to 2009, 40,687 Koreans were enrolled in the study 
and observed for the development of NL at a health promotion center. The examination 
included anthropometric and biochemical measurements as well as kidney 
ultrasonography. A student’s t-test or chi-square test was used to characterize the par-
ticipants and a standard Cox proportional hazards model was used to calculate the ad-
justed odds ratio of lithogenic risk factors in the NL model.
Results: The mean age of the study cohort was 44.9 years (range, 13-100 years), and 
22,540 (55.4%) of the cohort was male. The incidence of NL was 1.5% (609 participants), 
with males exhibiting a higher incidence than females (1.9% vs 1.0%, p＜0.01). Among 
the total cohort, MS as well as each trait of MS were risk factors for NL. In males, high 
body mass index (BMI), high blood pressure, and abnormal glucose metabolism were 
significant lithogenic factors, whereas in females, lithogenic factors included only high 
BMI and abnormal glucose metabolism.
Conclusions: MS is a significant lithogenic factor compared with other lithogenic 
factors. There was a correlated change in the prevalence of MS and NL and MS traits 
in Korea.
Key Words: Body mass index; Gender identity; Metabolic syndrome X; Nephrolithiasis; 
Obesity 
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INTRODUCTION
Recent articles from several countries have suggested a 
worldwide increase in the prevalence of nephrolithiasis 
(NL) in parallel with the escalating rate of metabolic syn-
drome (MS) [1-3]. People with MS are known to be at in-
creased risk of diabetes and cardiovascular disease, and in 
addition to these associations, MS sufferers have recently 
been identified as being at high risk of chronic kidney dis-
eases [4,5]. Furthermore, some of the traits of MS have been 
associated with the prevalence of NL [6,7]. Not only in Italy 
but also in the Republic of Korea, the incidence of NL and 
MS has increased with improvement in living conditions 
since the 1970s [8]. Although it has been suggested that this 
trend is a result of influence of Western lifestyles and diet-
ary habits, it remains unclear as to whether the increased 
prevalence of NL relative to that of MS is due to such diet 
and lifestyle modifications.
In Korean people, obesity has been identified as a risk 
factor for NL or lithogenic factors in a few studies; however, 
these results either stemmed from hospital populations, 
not a generalized cohort, or had subjective evidence of NL 
only [9,10]. Therefore, we investigated the association be-
tween NL and MS in a large cohort and a generalized pop-
ulation, as well as the association between NL and MS over 
a 15-year period to show the real effects of MS on the in-Korean J Urol 2011;52:548-553
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TABLE 1. Baseline characteristics of the study population
Entire cohort Males Females p-value
No. of patients
Age (yr)
BMI (kg/m
2)
Serum uric acid (mg/dl)
Serum calcium (mg/dl)
Serum phosphorus (mg/dl)
Serum sodium (mg/dl)
Cr (mg/dl)
eGFR (ml/min/1.73 m
2)
Echographic evidence of NL (%)
Metabolic syndrome 
MS traits (%)
    High BMI (%)
    High BP (%)
    Abnormal glucose metabolism (%)
    High serum TG (%)
    Low serum HDL-cholesterol (%)
40,687
  44.9±11.5
23.7±3.4
  4.94±1.81
  9.21±1.46
  3.62±1.16
143.6±7.5
  0.91±0.30
  87.5±19.3
   609 (1.50)
7,803 (19.2)
13,252 (32.6)
14,908 (36.6)
4,192 (10.3)
11,894 (29.2)
12,198 (30.0)
22,540
  44.5±11.3
24.0±3.0
  5.68±1.80
  9.27±1.21
  3.54±1.18
143.7±6.7
  1.02±0.30
  88.0±19.3
 434 (1.9)
4,902 (21.7)
8,038 (35.7)
9,296 (41.2)
2,811 (12.5)
8,486 (37.6)
5,384 (23.9)
18,147
  45.5±11.8
23.3±3.7
  4.04±1.36
  9.13±1.72
  3.72±1.12
143.6±8.3
  0.78±0.23
  86.9±19.2
 175 (1.0)
2,901 (16.0)
5,214 (28.7)
5,612 (30.9)
1,381 (7.6)
3,408 (18.8)
6,814 (37.5)
＜0.01
＜0.01
＜0.01
＜0.01
＜0.01
     0.087
＜0.01
＜0.01
＜0.01
＜0.01
＜0.01
＜0.01
＜0.01
＜0.01
＜0.01
Values expressed as mean±SD or number (percent). BMI: body mass index, Cr: creatinine, eGFR: estimated glomerular filtration rate,
BP: blood pressure, TG: triglyceride, HDL cholesterol: high-density lipoprotein cholesterol
cidence of NL by using objective evidence from the Korean 
population.
MATERIALS AND METHODS
1. Study population
From 1995 to 2009, we enrolled 40,687 Korean participants 
from a health promotion center in our hospital. This study 
was approved by the Institutional Review Board, and the 
established health examinations included physical exami-
nations, anthropometric measurements, biochemical 
measurements, and kidney ultrasonography (US). Data 
were analyzed retrospectively on the basis of information 
in the patients' medical records.
2. Measurements
Weights and heights were measured, and body mass in-
dexes (BMIs, the weight in kilograms divided by the square 
of the height in meters) were calculated. Systolic and dia-
stolic blood pressure (BP) were measured while the sub-
jects were seated, and fasting venous blood specimens were 
collected for the measurement of serum levels of glucose, 
HDL-cholesterol, triglycerides, total calcium, uric acid, 
phosphate, and creatinine. The estimated glomerular fil-
tration rate (eGFR) was calculated by using the abbre-
viated equation developed by the Modification of Diet in 
Renal Disease (MDRD) study: eGFR=186x(serum crea-
tinine level)
-1.154xa g e
-0.203 [11]. Ultrasonographic inspec-
tion of the renal pelvis and parenchyma in multiple ana-
tomic planes was performed in each subject by using a 
3.5-MHz transducer (Voluson 730, General Electronic, 
Milwaukee, WI, USA). According to Schepens et al renal 
calcifications were categorized as NL if the calcification 
was located in the collecting system and as nephrocalci-
nosis if the calcification occurred within the renal paren-
chyma [12]. All US evaluations were performed by techni-
cians who were unaware of the patients’ metabolic status.
The diagnosis of MS was made according to a recent re-
port by the National Cholesterol Education Program’s 
Third Adult Treatment Panel (NCEP ATP III). It was de-
fined as the presence of three or more of the following meta-
bolic criteria. Elevated BP was defined as a systolic BP≥
130 mmHg and/or diastolic BP≥85 mmHg; abnormal glu-
cose metabolism was defined as ≥110 mg/dl; high serum 
triglyceride level was defined as ≥150 mg/dl; and low HDL 
cholesterol level was defined as ≤40 mg/dl in men or ≤50 
mg/dl in women. Finally, BMI was replaced with waist cir-
cumference (WC) in the obese range (＞25 kg/m
2) by using 
the standards for Asian populations [13].
3. Statistical analysis
SPSS ver. 14.0 (SPSS Inc., Chicago, IL, USA), was used for 
the statistical analysis, considering p-values of less than 
0.05 as significant. The results were expressed as mean± 
standard deviation (SD) or proportion values. Data from 
participants with MS and those without were compared by 
using the Student’s t-test or chi-square test. The data from 
participants with NL and those without were also analyzed 
by using the same methods. We compared not only MS and 
NL but also a number of MS traits, that is, individual com-
ponents of MS and NL. To identify the risk factors of NL, 
the analyzed data were adjusted for multiple covariates. 
In the multivariate model, we included the following varia-
bles that may have confused the relationship between MS 
and NL: age, gender, GFR, serum uric acid, and phospho-
rus and calcium levels. Korean J Urol 2011;52:548-553
550 Jung et al
RESULTS
We studied 40,687 participants, including 22,540 (55.4%) 
men and 18,147 (44.6%) women. The participants’ mean 
age was 44.9±11.5 years (range, 13 to 100 years). General 
characteristics of the study participants are presented in 
Table 1. Overall, 7,803 (19.2%) had MS, and 609 (1.5%) had 
NL. Male participants were older (p＜0.01) and had a high-
er incidence of MS (p＜0.01) and NL (p＜0.01) than did fe-
male participants. Moreover, male participants had a 
higher incidence of all MS traits than did female 
participants.
We investigated the difference in clinical and metabolic 
characteristics according to the echographic evidence of 
NL in all participants, and these results are presented in 
Table 2. Among the entire cohort, participants with NL 
were older than participants without NL and had higher 
levels of serum uric acid, serum calcium, and serum crea-
tinine as well as lower GFRs than did participants without 
NL. Furthermore, the incidence of MS was higher in partic-
ipants with NL, and the incidences of each MS trait other 
than low serum HDL-cholesterol were higher in partic-
ipants with NL. 
When we divided the participants into genders and com-
pared clinical and metabolic characteristics according to 
the presence of NL, male and female participants with NL 
were older, more obese, and showed lower GFRs than did 
the participants without NL. Moreover, the incidences of 
MS, high BP, and abnormal glucose metabolism were high-
er in participants with NL in both males and females. 
However, the levels of serum uric acid, serum calcium, and 
serum sodium were not significantly different between the 
male participants with NL and those without, although dif-
ferences did exist in female participants.
We also assessed whether the relationship between MS 
and NL was related to the number of MS traits in the total 
cohort. The prevalence of 0, 1, 2, 3, 4, and 5 traits of MS was 
1.12%, 1.45%, 1.51%, 2.04%, 2.16%, and 3.23% in the total 
population; 1.42%, 1.91%, 1.90%, 2.54%, 2.58%, and 2.55% 
in males; and 0.85%, 0.90%, 0.90%, 1.13%, 1.51%, and 
4.00% in females, respectively. As the number of MS traits 
increased, the frequency of echographic evidence of NL 
generally increased in the total cohort and also in male and 
female participants. In particular, echographic evidence of 
NL in females increased by almost 3-fold from 4 to 5 traits 
(1.51% to 4.00%) (Fig. 1). 
To identify lithogenic factors, we performed a multi-
variate logistic regression analysis (Fig. 2). As reported in 
the figure, this model included the entire study population 
and confirmed that age (odds ratio [OR]: 1.022; 95% con-
fidence interval [CI]: 1.014-1.029; p＜0.05), male gender 
(OR: 2.030; 95% CI: 1.672-2.465; p＜0.05), occurrence of 
MS (OR: 1.359; 95% CI: 1.128-1.638; p＜0.05), and esti-
mated GFR (OR: 0.994; 95% CI: 0.988-0.999; p＜0.05) were 
each significantly and independently related to echo-
graphic evidence of NL. With respect to the total sum of MS 
traits, the results were as follows: one MS trait (OR: 1.173; 
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FIG. 2. Multivariate odds ratio of lithogenic factors for echographic evidence of nephrolithiasis. The sum of metabolic syndrome traits
and individual metabolic syndrome traits were adjusted for age, GFR, serum uric acid, and phosphorus and calcium levels. GFR: 
glomerular filtration rate, MS: metabolic syndrome, BMI: body mass index, OR: odds ratio, CI: confidence interval.
FIG. 1. Relationship between metabolic syndrome and echo-
graphic evidence of nephrolithiasis.
95% CI: 0.927-1.485; p＜0.05), two MS traits (OR: 1.101; 
95% CI: 0.856-1.415; p＜0.05), three MS traits (OR: 1.419; 
95% CI: 1.085-1.857; p＜0.05), four MS traits (OR: 1.520; 
95% CI: 1.073-2.152; p＜0.05), five MS traits (OR: 2.353; 
95% CI: 1.283-4.317; p＜0.05). Regarding individual MS 
traits, high BMI (OR: 1.338; 95% CI: 1.124-1.593; p＜0.05), 
high BP (OR: 1.264; 95% CI: 1.062-1.504; p＜0.05), abnor-
mal glucose metabolism (OR: 1.296; 95% CI: 1.028-1.635; 
p＜0.05), high serum triglyceride (OR: 0.887; 95% CI: 
0.735-1.072; p＜0.05), and low HDL-cholesterol (OR: 
0.926; 95% CI: 0.763-1.124; p＜0.05) were each sig-
nificantly and independently related to echographic evi-
dence of NL upon adjustment for multiple covariates in-
cluding age, GFR, serum uric acid, phosphorus, and cal-
cium level.
DISCUSSION
A previous study demonstrated an increase in the preva-
lence and incidence of NL in the United States and other 
parts of the world. This article showed that diet and climate 
had the most significant impact on these trends [14]. It has 
been suggested that climatic factors may be associated 
with high temperature and low humidity and that dietary 
factors may be related to increased consumption of starch 
and fat, thus promoting MS through traits such as obesity, 
diabetes, and hypercholesterolemia [15,16]. 
Furthermore, there has been much research regarding 
the association between MS and NL. West et al reviewed 
data from 14,670 men and women older than 20 years who 
participated in the National Health and Nutrition 
Examination Survey (NHANES III) from 1988 and 1994 
[7]. In that study, the presence of MS was associated with 
a two-fold increase in the OR of self-reported NL (2.13; 95% 
CI: 1.74 to 2.62) compared with adults without MS, and this 
OR decreased to 1.52 (95% CI: 1.22 to 1.89) after adjust-
ment for age, sex, and race. In another study, Rendina et Korean J Urol 2011;52:548-553
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al reviewed 2,132 Caucasian inpatients in southern Italy 
and found that the presence of MS was independently re-
lated to echographic evidence of NL and was associated 
with a two-fold greater frequency of objectively demon-
strated NL (OR: 2.01, 95% CI: 1.34 to 3.28) [8]. On the basis 
of these two studies, it is conceivable that MS is an in-
dependent risk factor of NL. In our study, we found a rela-
tionship between MS and NL; therefore, our results sup-
port the previous conclusions of MS as an independent risk 
factor for NL.
Insulin resistance (IR), which plays a critical role in the 
initiation and maintenance of the various clinical features 
of MS [17], has been identified as a common pathogenic 
background between MS and NL. It has been suggested 
that IR may manifest in the kidney as a defect in ammo-
nium production and the ability to excrete acid, thus affect-
ing urine pH [18]. In fact, recent data have confirmed that 
IR in humans is associated with lower urine pH [19]. 
Hyperinsulinemia could also lead to decreased urinary cit-
rate and increased urinary excretion of calcium, uric acid, 
and oxalate, which are important risk factors for calcium 
and uric acid NL [19,20]. In our study, there was no sig-
nificant statistical association between the number of 
traits of MS and the urine pH (data not shown). Probably, 
this irrelevance was due to the method of collecting the 
urine. Kamel et al measured the urine pH in 24-hour col-
lected urine [18]; however, we measured the urine pH of a 
random spot urine sample. In the future, we will analyze 
24-hour urine collections for measuring urine pH.
Our study had some limitations. The strengths of our 
study include the large number of cases and long average 
length of observation. A corresponding limitation of our 
study was a lack of exclusion criteria and a lack of patient 
history about previous NL. This problem could cause cer-
tain statistical biases. However, it was practically difficult 
to collect information about the approximately 40,000 
participants. Likewise, the difference between the size of 
the cohort of each gender could cause a certain statistical 
bias. The male cohort numbered 22,106 and the female co-
hort numbered 17,972. Thus, statistical power would have 
a greater influence in the male cohort than in the female 
cohort.
Second, we lacked 24-hour urine collections and compo-
sition analyses of stones from most of the participants in 
our study. Thus, we were unable to determine whether MS 
increased the risk of certain NL types and not others. We 
also could not ascertain whether differences in urine com-
position (urinary calcium, phosphate, urate, oxalate, and 
citrate excretion) were responsible for the effect of the asso-
ciation between MS and NL.
Third, our participants were persons who visited a 
health promotion center. We can presume that they paid 
careful attention to their own health and they may have 
been members of middle-class families. Therefore, we need 
further large-scale studies in general populations of 
Koreans to evaluate the effect of MS on the risk of NL.
Fourth, US was used as the imaging modality to assess 
NL rather than noncontrast computed tomography (CT). 
The latter is known to be more sensitive for detecting NL 
and has largely replaced US for the evaluation of patients 
with symptoms of acute renal colic [21,22]. However, in our 
study, we used US as part of a comprehensive health exami-
nation because US had many advantages, including lack 
of radiation exposure, wide availability, and low cost de-
spite its lower sensitivity than CT and false-positives. 
These findings may warrant future prospective studies us-
ing imaging modalities with higher sensitivity and less 
invasiveness.
Finally, we used a modified NCEP ATP III of MS using 
BMI instead WC. However, a number of studies have 
shown that BMI should be used instead of WC for predict-
ing the development of type 2 diabetes and other metabolic 
disturbances, and BMI rather than WC recently was adopt-
ed for the analysis of MS [23]. Despite these potential limi-
tations, this is the first study to show the association be-
tween MS and incident NL in healthy Korean populations. 
The strength of this study is the large sample size and ob-
jective US evaluation, which allowed us to perform strati-
fied subgroup analysis according to gender over a 15-year 
period.
CONCLUSIONS
Metabolic syndrome is a significant lithogenic factor com-
pared with other lithogenic factors. There was a correlated 
change in the prevalence of MS and NL and MS traits in 
Korea.
There was a significantly different gender distribution, 
and this difference was correlated with the prevalence of 
MS. There were particular changes in the prevalence of MS 
and NL and MS traits in Korea. Females exhibited a de-
creased tendency, whereas males showed an increased ten-
dency, with respect to the prevalence of MS traits. Thus, 
in Korean men particularly, weight loss and exercise can 
serve as a protective factor against an increased risk of NL.
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